Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
International Neurourology Journal
>
2016
>
20
>
1
Volume:
20
Issue:
1
1. Update on the Pathology and Diagnosis of Interstitial Cystitis/Bladder Pain Syndrome: A Review.
Page:13—17
2. 17Beta-Estradiol Inhibits Calcium-Activated Potassium Channel Expressions in Rat Whole Bladder.
Page:18—25
3. Changes in Synaptic Transmission and Long-term Potentiation Induction as a Possible Mechanism for Learning Disability in an Animal Model of Multiple Sclerosis.
Page:26—32
4. Eight-Year Experience With Botulinum Toxin Type-A Injections for the Treatment of Nonneurogenic Overactive Bladder: Are Repeated Injections Worthwhile?.
Page:40—46
5. Assessment of Proportion of Hidden Patients Having Symptoms of Overactive Bladder and Why Has It Been Hidden in Female Outpatients Admitted to Hospital.
Page:47—52
6. Comparison of Predictive Factors for Postoperative Incontinence of Holmium Laser Enucleation of the Prostate by the Surgeons' Experience During Learning Curve.
Page:59—68
7. Effect of Nerve-Sparing Radical Prostatectomy on Urinary Continence in Patients With Preoperative Erectile Dysfunction.
Page:69—74
8. Interstitial Cystitis/Bladder Pain Syndrome: A Urologic Mystery.
Page:3—4
9. Learning From Heart Failure: How Will We Lead Bladder Failure Into the Future?.
Page:1—2
10. Rescue of Heart Failure by Mitochondrial Recovery.
Page:5—12
11. Lower Levels of Urinary Nerve Growth Factor Might Predict Recurrent Urinary Tract Infections in Women.
Page:33—39
12. Weakness of the Pelvic Floor Muscle and Bladder Neck Is Predicted by a Slight Rise in Abdominal Pressure During Bladder Filling: A Video Urodynamic Study in Children.
Page:53—58
13. Clinical Significance of the Resistive Index of Prostatic Blood Flow According to Prostate Size in Benign Prostatic Hyperplasia.
Page:75—80
14. Intravesical OnabotulinumtoxinA Injection for Overactive Orthotopic Ileal Neobladder: Feasibility and Efficacy.
Page:81—85